3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
23
Prostatic Neoplasms
12
Lung Neoplasms
12
Colorectal Neoplasms
12
Neoplasms
9
Pancreatic Neoplasms
6
Lymphoma
6
Hematologic Neoplasms
6
Uterine Cervical Neoplasms
5
Ovarian Neoplasms
5
Triple Negative Breast Neoplasms
4
Neoplasm Metastasis
4
Melanoma
4
Hematopoietic and Lymphatic System Neoplasm
4
Urinary Bladder Neoplasms
3
Sarcoma
3
Papillomavirus Infections
3
Obesity-Related Malignant Neoplasm
3
Obesity
3
Motor Activity
3
Endometrial Neoplasms
3
Colonic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Breast Carcinoma In Situ
3
Anatomic Stage I Breast Cancer AJCC v8
3
Vulvar Neoplasms
2
Testicular Neoplasms
2
Smoking Cessation
2
Skin Carcinoma
2
Rectal Neoplasms
2
Interventions
Carboplatin
9
pembrolizumab
7
Pemetrexed
7
Radiotherapy
5
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Radiation
4
Nivolumab
4
Bevacizumab
4
Platinum
3
Paclitaxel
3
Mastectomy, Segmental
3
Cisplatin
3
Biopsy
3
fludarabine phosphate
2
durvalumab
2
capmatinib
2
aldesleukin
2
Taxes
2
Radiotherapy, Conformal
2
Radiosurgery
2
Ipilimumab
2
Interleukin-2
2
Immunoglobulin G
2
Disulfides
2
Cyclophosphamide
2
CTLA-4 Antigen
2
Anterior Temporal Lobectomy
2
1,2-diaminocyclohexaneplatinum II citrate
2
veliparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma of Lung
×
Methods
×
1 year
×
Clear all
No trials found.